Clonal alterations in hematopoietic cells occur during aging and are often associated with
the establishment of a subclinical inflammatory environment. Several age-related conditions …

Simple Summary There is growing evidence that Ph-negative myeloproliferative neoplasms
are disorders in which multiple signaling pathways are significantly disturbed. The …

Essential thrombocythemia (ET) is characterized by abnormal megakaryopoiesis and
enhanced thrombotic risk. Once-daily low-dose aspirin is the recommended antithrombotic …

In patients with Myelofibrosis (MF) treated with ruxolitinib (RUX), the response is
unpredictable at therapy start. We retrospectively evaluated the impact of clinical/laboratory …

Current therapies for myeloproliferative neoplasms (MPNs) improve symptoms but have
limited effect on tumor size. In preclinical studies, tamoxifen restored normal apoptosis in …

The factors underlying the variable presentation and clinical course of myeloproliferative
neoplasms (MPNs) remain unclear. The aim of this study was to evaluate the independent …

Background This study was conducted to identify clinicodemographic risk factors for
xerostomia among long‐term oropharyngeal cancer (OPC) survivors. Methods This cross …

Myeloproliferative neoplasms (MPNs) are haematopoietic stem cell-derived clonal disorders
characterised by proliferation of some or all myeloid lineages, depending on the subtype …

Objectives: This systematic review aims to assess and explore various determinants of
cancer-related fatigue. Methods: A systematic search of various determinants of Cancer …

Polycythemia vera is a Philadelphia-negative chronic myeloproliferative neoplasm,
characterized by erythrocytosis, which is unique, compared to essential thrombocytosis and …